S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
S&P 500   3,977.53 (+0.16%)
DOW   32,432.08 (+0.60%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:IMTX

Immatics - IMTX News Today

$7.15
+0.41 (+6.08%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$6.60
$7.26
50-Day Range
$6.74
$8.88
52-Week Range
$5.75
$13.60
Volume
784,410 shs
Average Volume
228,705 shs
Market Capitalization
$545.04 million
P/E Ratio
9.66
Dividend Yield
N/A
Price Target
$22.33
Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter.


IMTX Media Mentions By Week

IMTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMTX
News Sentiment

0.71

0.67

Average
Medical
News Sentiment

IMTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMTX Articles
This Week

17

1

IMTX Articles
Average Week

SourceHeadline
marketbeat.com logoImmatics (NASDAQ:IMTX) Receives New Coverage from Analysts at Bryan, Garnier & Co
marketbeat.com - March 24 at 9:21 AM
marketbeat.com logoImmatics to Post Q1 2023 Earnings of ($0.42) Per Share, SVB Leerink Forecasts (NASDAQ:IMTX)
marketbeat.com - March 23 at 6:58 AM
MarketBeat logoImmatics (NASDAQ:IMTX) Research Coverage Started at Bryan, Garnier & Co
americanbankingnews.com - March 27 at 2:52 AM
MarketBeat logoImmatics (NASDAQ:IMTX) Given New $25.00 Price Target at Chardan Capital
americanbankingnews.com - March 26 at 4:24 AM
MarketBeat logoImmatics (NASDAQ:IMTX) Forecasted to Earn Q1 2023 Earnings of ($0.42) Per Share
americanbankingnews.com - March 25 at 1:52 AM
MarketBeat logoImmatics Forecasted to Post FY2023 Earnings of ($1.71) Per Share (NASDAQ:IMTX)
americanbankingnews.com - March 24 at 6:52 AM
finance.yahoo.com logoImmatics Announces Full Year 2022 Financial Results and Corporate Update
finance.yahoo.com - March 21 at 7:54 AM
MarketBeat logoImmatics (IMTX) Set to Announce Earnings on Tuesday
americanbankingnews.com - March 20 at 9:00 AM
MarketBeat logoImmatics (IMTX) Set to Announce Quarterly Earnings on Tuesday
americanbankingnews.com - March 20 at 8:08 AM
finance.yahoo.com logoThe past three years for Immatics (NASDAQ:IMTX) investors has not been profitable
finance.yahoo.com - March 20 at 6:46 AM
MarketBeat logoImmatics (NASDAQ:IMTX) Sees Significant Growth in Short Interest
americanbankingnews.com - March 17 at 9:34 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Immatics (IMTX)
markets.businessinsider.com - February 6 at 10:00 AM
finance.yahoo.com logoImmatics N.V.'s (NASDAQ:IMTX) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - December 17 at 10:09 AM
reuters.com logoIMTX.O - Immatics NV | Stock Price & Latest News | Reuters
reuters.com - December 16 at 10:49 PM
finance.yahoo.com logoImmatics Announces Third Quarter 2022 Financial Results and Business Update
finance.yahoo.com - November 17 at 10:44 AM
finance.yahoo.com logoImmatics (IMTX) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 17 at 10:44 AM
finance.yahoo.com logoDoes Immatics (IMTX) Have the Potential to Rally 77% as Wall Street Analysts Expect?
finance.yahoo.com - October 31 at 12:30 PM
msn.com logoWall Street Analysts See an 81% Upside in Immatics (IMTX): Can the Stock Really Move This High?
msn.com - October 14 at 3:07 PM
nz.finance.yahoo.com logoShareholders in Immatics (NASDAQ:IMTX) are in the red if they invested a year ago
nz.finance.yahoo.com - October 10 at 3:41 PM
seekingalpha.com logoHot Stocks: Macau stocks drop on COVID worries; EDU, TAL plunge; AXNX downgrade; IMTX rises on clinical data
seekingalpha.com - October 10 at 3:41 PM
msn.com logoImmatics Immunotherapy Candidate Shows Confirmed Responses In Different Solid Cancers
msn.com - October 10 at 10:41 AM
finance.yahoo.com logoImmatics Reports Interim Clinical Data Update on ACTengine® IMA203 TCR-T Monotherapy Targeting PRAME
finance.yahoo.com - October 10 at 10:41 AM
finance.yahoo.com logoImmatics Announces $110 Million Underwritten Offering of Ordinary Shares
finance.yahoo.com - October 10 at 10:41 AM
seekingalpha.com logoIMTX Immatics N.V.
seekingalpha.com - September 27 at 8:15 PM
nasdaq.com logoFurther weakness as Immatics (NASDAQ:IMTX) drops 11% this week, taking one-year losses to 26%
nasdaq.com - September 13 at 7:06 PM
reuters.com logoIMTX.OQ - Immatics NV | Stock Price & Latest News | Reuters
reuters.com - August 29 at 6:05 PM
finanznachrichten.de logoImmatics Announces First Cancer Patient Treated with Second-Generation ACTengine TCR-T Candidate IMA203CD8 Targeting PRAME
finanznachrichten.de - August 24 at 8:49 PM
finance.yahoo.com logoImmatics Announces First Cancer Patient Treated with Second-Generation ACTengine® TCR-T Candidate IMA203CD8 Targeting PRAME
finance.yahoo.com - August 23 at 2:45 PM
finance.yahoo.com logoWall Street Analysts Think Immatics (IMTX) Could Surge 82%: Read This Before Placing a Bet
finance.yahoo.com - August 12 at 12:59 PM
nz.finance.yahoo.com logoImmatics Announces Second Quarter 2022 Financial Results and Business Update
nz.finance.yahoo.com - August 9 at 8:33 AM
nasdaq.com logoStrength Seen in Immatics (IMTX): Can Its 18% Jump Turn into More Strength?
nasdaq.com - July 20 at 1:34 PM
finance.yahoo.com logoDo Its Financials Have Any Role To Play In Driving Immatics N.V.'s (NASDAQ:IMTX) Stock Up Recently?
finance.yahoo.com - June 25 at 5:30 PM
morningstar.com logoImmatics NV Ordinary Shares - Stock Chart
morningstar.com - June 17 at 10:53 PM
seekingalpha.com logoEditas in licensing deal with Immatics for cancer therapies
seekingalpha.com - June 9 at 6:28 AM
seekingalpha.com logoImmatics GAAP EPS of €1.35, revenue of €102.91M
seekingalpha.com - June 2 at 10:19 AM
finance.yahoo.com logoImmatics Announces First Quarter 2022 Financial Results and Business Update
finance.yahoo.com - June 2 at 10:19 AM
finance.yahoo.com logoImmatics (IMTX) Lags Q1 Earnings and Revenue Estimates
finance.yahoo.com - June 2 at 10:19 AM
seekingalpha.com logoImmatics stock rises on cell therapy program collaboration with Bristol Myers
seekingalpha.com - June 2 at 10:19 AM
finance.yahoo.com logoWhat Kind Of Shareholders Own Immatics N.V. (NASDAQ:IMTX)?
finance.yahoo.com - May 26 at 9:48 AM
morningstar.com logoImmatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumors
morningstar.com - May 10 at 7:52 AM
markets.businessinsider.com logoImmatics Initiates Phase 1 Clinical Trial of IMA401 in Advanced Solid Tumors
markets.businessinsider.com - May 10 at 7:52 AM
finance.yahoo.com logoImmatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumors
finance.yahoo.com - May 10 at 7:52 AM
finance.yahoo.com logoImmatics (NASDAQ:IMTX) shareholders have endured a 37% loss from investing in the stock a year ago
finance.yahoo.com - May 3 at 1:35 PM
finance.yahoo.com logoWall Street Analysts See a 178% Upside in Immatics (IMTX): Can the Stock Really Move This High?
finance.yahoo.com - April 15 at 2:21 PM
finance.yahoo.com logoAnalysts Are Optimistic We'll See A Profit From Immatics N.V. (NASDAQ:IMTX)
finance.yahoo.com - March 31 at 6:36 PM
finanznachrichten.de logoImmatics Announces Full Year 2021 Financial Results and Corporate Update
finanznachrichten.de - March 25 at 12:05 AM
benzinga.com logoImmatics Cash Position As Of Dec. 31 $164.3M
benzinga.com - March 23 at 9:48 AM
finance.yahoo.com logoHere's Why We're Watching Immatics' (NASDAQ:IMTX) Cash Burn Situation
finance.yahoo.com - February 14 at 3:35 PM
nasdaq.com logoNews Flash: Analysts Just Made A Captivating Upgrade To Their Immatics N.V. (NASDAQ:IMTX) Forecasts
nasdaq.com - December 16 at 6:10 AM
finance.yahoo.com logoNews Flash: Analysts Just Made A Substantial Upgrade To Their Immatics N.V. (NASDAQ:IMTX) Forecasts
finance.yahoo.com - December 16 at 6:10 AM
bizjournals.com logoImmatics inks $920M licensing deal with Bristol Myers Squibb
bizjournals.com - December 14 at 7:50 AM
marketwatch.com logoBristol Myers, Immatics to Collaborate on IMA401 >BMY IMTX
marketwatch.com - December 14 at 7:50 AM
Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:IMTX) was last updated on 3/27/2023 by MarketBeat.com Staff